Search
for

    GlossaryImatinib

    targets specific enzymes to treat certain cancers like CML

    Imatinib, also known as Gleevec, is a targeted cancer therapy drug used primarily to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific tyrosine kinases, which are enzymes that promote the growth of cancer cells, thereby slowing or stopping the progression of the disease.

    Related Terms

    Sort by

    Learn

    5 / 801 results

      learn Tofacitinib

      a JAK inhibitor for alopecia areata and other autoimmune conditions

      learn Baricitinib

      JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

      learn PP405

      mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
    Next page →